ImmunoCellular Therapeutics (IMUCD) Stock Chart & Stock Price History $0.17 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Chart Stock AnalysisChart ImmunoCellular Therapeutics Stock Price Performance 5 Day Performance-0.06%1 Month Performance+60.86%3 Month Performance+36.21%6 Month Performance-11.11%Year-To-Date Performance-27.20%1 Year Performance-6.69% Receive IMUCD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ImmunoCellular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now IMUCD Stock Chart for Sunday, December, 22, 2024 IMUCD Chart by TradingView ImmunoCellular Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.17$0.17$0.17$0.101,461 shs$708,000.0012/19/2024$0.17$0.17$0.17$0.101,461 shs$708,000.0012/18/2024$0.17$0.17-0.06%$0.17$0.101,461 shs$708,000.0012/17/2024$0.18$0.17-5.06%$0.18$0.103,973 shs$708,000.0012/16/2024$0.18$0.18$0.18$0.10103 shs$746,000.0012/13/2024$0.18$0.18-1.11%$0.18$0.145,129 shs$746,000.00 Get the Latest News and Ratings for IMUCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoCellular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$0.18$0.18$0.18$0.101,283 shs$754,000.0012/11/2024$0.18$0.18$0.18$0.1840 shs$754,000.0012/10/2024$0.18$0.18$0.18$0.148,107 shs$754,000.0012/09/2024$0.18$0.18$0.18$0.12438 shs$754,000.0012/06/2024$0.18$0.18$0.18$0.121,102 shs$754,000.0012/05/2024$0.18$0.18$0.18$0.14204 shs$754,000.0012/04/2024$0.17$0.18+3.51%$0.18$0.1210,617 shs$754,000.0012/03/2024$0.17$0.17+2.29%$0.17$0.11208 shs$729,000.0012/02/2024$0.17$0.17$0.17$0.17123 shs$712,000.0011/29/2024$0.17$0.17$0.17$0.131,003 shs$729,000.0011/28/2024$0.15$0.17+16.32%$0.17$0.131,003 shs$729,000.0011/27/2024$0.17$0.15-14.03%$0.15$0.111,100 shs$626,000.0011/26/2024$0.17$0.17+2.29%$0.17$0.16208 shs$729,000.0011/25/2024$0.17$0.17$0.17$0.15407 shs$712,000.0011/22/2024$0.20$0.11-47.50%$0.18$0.111,207 shs$440,000.0011/21/2024$0.20$0.20$0.20$0.152,103 shs$838,000.00 Related Companies ENTO Stock Chart MYMD Stock Chart PALI Stock Chart NBY Stock Chart BIOR Stock Chart ZVSA Stock Chart AOXG Stock Chart SPRC Stock Chart SHPH Stock Chart APVO Stock Chart Receive IMUCD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ImmunoCellular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:IMUCD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoCellular Therapeutics, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoCellular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
